Least bothered, very good details here.
If 1mg want to play a price-war then they should also really enter the govt tender biz. It gives them assured long-term contracts with volumes and price escalations built-in.
A price-war is the best scenario for Krsnaa, since they have demonstrated proof of running the cheapest diagnostics very profitably for a long time. It may hurt margins a little when they start trying to scale to B2C model as well. Though it may also help overall in positioning of cheap tests as being reliable.